Condition: Cystic Fibrosis (CF) · Bronchiectasis Adult · Sponsor: Papworth Hospital NHS Foundation Trust
The goal of this observational study is to learn about new sensors that measure changes in the body that happen during a chest infection, such as breathing rate and heart rate. This study will be with adults who have either cystic fibrosis or bronchiectasis who start treatment with intravenous antibiotics (usually for around 2 weeks). The main question it aims to answer is the change in sensor measure (such as heart rate) between the start and end of treatment for a chest infection. No follow up visits are required for this study.
This description comes directly from the study's public registry record.
Lucy E Gale · +44 1223 638000 · lucy.gale1@nhs.net
Victoria Hughes, PhD · +44 1223 638000 · victoria.hughes1@nhs.net
Always discuss trial participation with your own doctor first.
| Royal Papworth Hospital NHS Foundation Trust | Cambridge, Cambridgeshire, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07289100